Diginex's Shareholder Vote: A Pivot Point for Nasdaq and Strategy

Diginex faces a crucial vote on a reverse stock split to avoid Nasdaq delisting, as its ESG software revenue surges 293% despite widening losses.

Diginex, a specialist in ESG and carbon accounting software, faces a decisive moment. On April 13, shareholders will cast votes that will determine the immediate fate of its Nasdaq listing and shape the company's ongoing strategic transformation. The dual proposals—a share consolidation and a capital increase—are a direct response to a formal Nasdaq warning received in late March after the stock traded below the critical $1.00 threshold for 30 consecutive sessions.

The proposed 8-for-1 reverse stock split is a technical maneuver designed to lift the share price above the $1.00 compliance level. The company emphasizes this action does not alter proportional ownership or market capitalization in any material way. If approved and the post-split price holds above $1.00 for ten consecutive trading days, the imminent delisting threat would be temporarily averted. The parallel proposal seeks to increase the company’s authorized share capital to $200,000, divided into common and preferred stock.

This corporate action unfolds against a backdrop of significant operational change and stark financial contrasts. Diginex has been actively consolidating four formerly independent subsidiaries into a single, integrated technology platform. The goal is to offer a comprehensive solution for CO2 accounting and sustainability reporting tailored for institutional clients like banks and asset managers, a market segment growing due to regulations such as the European CSRD and SFDR.

This strategic pivot is already fueling remarkable top-line growth. Revenue for the first half of the fiscal year surged 293% to $2.0 million, driven by higher subscription and license fees. Over the past twelve months, revenue climbed 203%. The company’s net assets stood at $10.9 million as of September 30, 2025, and it carries no interest-bearing debt. A warrant exercise in October 2025 added a further $13.8 million to the treasury, and current liquid assets exceed short-term liabilities.

Despite this explosive revenue growth and a solid balance sheet, Diginex remains unprofitable. Its operating loss widened to $6.0 million in the first half, up from $4.2 million a year earlier, indicating that sales growth has not yet caught up with the cost base. The company’s commercial strategy, however, continues to gain traction. A prominent reference project emerged in March 2026 when Doctolib SAS, Europe's largest health technology company, partnered with Diginex subsidiary Plan A for quarterly emissions reporting and decarbonization roadmap development.

Further commercial potential lies in a planned merger with marketing technology provider Resulticks. A resale agreement signed in February 2026 sets a cumulative revenue target of $40 million over four years. The completion of a full merger, however, remains uncertain as it is contingent on securing non-dilutive debt financing.

The April 13 vote is therefore a foundational step. Shareholder approval would clear the path to resolve the Nasdaq listing deficiency, allowing management to focus fully on detailing its integrated commercial strategy in the second quarter of 2026. The outcome will determine whether Diginex can secure its exchange listing to support its ambitious operational overhaul.